We are live on
!
Find out more
SC
Savant Capital Portfolio holdings
AUM
$20.7B
1-Year Est. Return
19.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.29%
1 Year Est. Return
+19.76%
3 Year Est. Return
+51.75%
5 Year Est. Return
+48.44%
10 Year Est. Return
+194.21%
AUM
$4.09B
AUM Growth
+$883M
(+28%)
Cap. Flow
+$853M
Cap. Flow
% of AUM
20.83%
Top 10 Holdings %
Top 10 Hldgs %
46.89%
Holding
619
New
73
Increased
346
Reduced
157
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$435M |
| 2 |
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
|
+$36.5M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$35.1M |
| 4 |
Avantis International Small Cap Value ETF
AVDV
|
+$27.2M |
| 5 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$182M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$13.6M |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$7.1M |
| 4 |
IQ ARB Merger Arbitrage ETF
MNA
|
+$5.02M |
| 5 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$4.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.11% |
| 2 | Technology | 2.9% |
| 3 | Industrials | 2.49% |
| 4 | Financials | 2.05% |
| 5 | Consumer Discretionary | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Cameco
CCJ
$39.1B
| $285K | 0.01% |
12,567
| – | – |
|
477
Quest Diagnostics
DGX
$25.6B
| $283K | 0.01% |
1,807
-409
| -18% | -$58.8K |
|
478
Newmont
NEM
$99.9B
| $281K | 0.01% |
5,958
+713
| +14% | +$31.8K |
|
479
United Rentals
URI
$69.6B
| $281K | 0.01% |
+827
| New | +$272K |
|
480
HEICO Corp
HEI
$50.2B
| $278K | 0.01% |
1,809
+36
| +2% | +$5.61K |
|
481
Diamondback Energy
FANG
$55.7B
| $277K | 0.01% |
2,049
+97
| +5% | +$14.2K |
|
482
Simon Property Group
SPG
$74.3B
| $277K | 0.01% |
2,355
+42
| +2% | +$4.67K |
|
483
Novartis
NVS
$292B
| $276K | 0.01% |
+3,559
| New | +$300K |
|
484
HCA Healthcare
HCA
$87.4B
| $276K | 0.01% |
+1,511
| New | +$338K |
|
485
iShares Silver Trust
SLV
$27.9B
| $275K | 0.01% |
12,497
+424
| +4% | +$8.3K |
|
486
Pultegroup
PHM
$24.4B
| $275K | 0.01% |
+6,043
| New | +$255K |
|
487
Oneok
OKE
$55.3B
| $274K | 0.01% |
+4,176
| New | +$257K |
|
488
Unilever
UL
$138B
| $273K | 0.01% |
5,168
+965
| +23% | +$51.6K |
|
489
Kinder Morgan
KMI
$69.9B
| $271K | 0.01% |
15,012
+2,703
| +22% | +$48.6K |
|
490
T. Rowe Price
TROW
$24.1B
| $270K | 0.01% |
3,038
+627
| +26% | +$70.9K |
|
491
Zimmer Biomet
ZBH
$18.6B
| $270K | 0.01% |
2,120
-107
| -5% | -$12.4K |
|
492
Estee Lauder
EL
$30.5B
| $270K | 0.01% |
1,087
-374
| -26% | -$83.5K |
|
493
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.29B
| $268K | 0.01% |
18,121
-13,652
| -43% | -$228K |
|
494
Williams Companies
WMB
$86.2B
| $267K | 0.01% |
8,115
+206
| +3% | +$6.71K |
|
495
Arrow Financial
AROW
$668M
| $266K | 0.01% |
8,086
+865
| +12% | +$27.9K |
|
496
Vertex Pharmaceuticals
VRTX
$120B
| $266K | 0.01% |
921
+142
| +18% | +$43.3K |
|
497
Biogen
BIIB
$29.8B
| $265K | 0.01% |
1,031
+158
| +18% | +$44.6K |
|
498
ServiceNow
NOW
$119B
| $264K | 0.01% |
3,395
+425
| +14% | +$33.2K |
|
499
Sprout Social
SPT
$522M
| $263K | 0.01% |
4,665
| – | – |
|
500
Clorox
CLX
$11.8B
| $262K | 0.01% |
1,899
+251
| +15% | +$35.6K |
|
Similar funds
VARA
CB
MIC
GT
EWA
MMH
P
Savant Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Savant Capital held 619 positions worth $4.09B, up 28% from $3.21B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Savant Capital deployed $853M of net new capital in Q4 2022, opening 73 new positions and adding to 346 existing holdings. Its largest new stake was iShares Ultra Short Duration Bond Active ETF: 475,147 shares worth $372K.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.7% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $182M trimmed.
- Savant Capital's largest Q4 2022 buy was iShares Ultra Short Duration Bond Active ETF: 475,147 shares worth $372K.
- Savant Capital added most to Avantis Emerging Markets Equity ETF in Q4 2022, an estimated $435M increase.
- Savant Capital's biggest Q4 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $182M.
- Savant Capital fully exited WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund in Q4 2022, selling an estimated $2.07M.
- Savant Capital's ten largest holdings make up 47% of its $4.09B portfolio in Q4 2022.
- Savant Capital opened 73 new positions and closed 15 in Q4 2022.
- Savant Capital's portfolio value rose 28% quarter-over-quarter to $4.09B.
Based on Savant Capital's 13F filing for Q4 2022, filed 7 Feb 2023.